Related Digital Materials | AME

All filters

Slidesets

Being Proactive - HIV Prevention in Adolescents | Magdalene Mayer

Presented at:

INTEREST 2016

Slidesets

Supporting Beyond Treatment - Care for HIV Positive Adolescents | Rama Diagne

Presented at:

INTEREST 2016

Slidesets

(Abstract) Decline in positivity rates among HIV-exposed infants with changes in PMTCT ARV regimens in Nigeria: evidence from 7 years of field implementation | H. Khamofu

Presented at:

INTEREST 2016

Slidesets

(Abstract) Favourable outcomes of paediatric second-line protease inhibitor-based antiretroviral treatment in Uganda | R.S. Boerma

Presented at:

INTEREST 2016

Slidesets

Transmitted Drug Resistance and First-line ART Treatment Outcomes in Ugandan Children | H. Mugerwa

Presented at:

INTEREST 2016

Slidesets

90-90-90 for all - Scale up of HIV Treatment for Adolescents | Victor Musiime, MBChB, MMED, PhD

Presented at:

INTEREST 2016

Slidesets

Formal Debate: Resolved that 90-90-90 Cannot be Attained | Affirming the motion | Mauro Schechter, MD, PhD

Presented at:

INTEREST 2016

Slidesets

(Abstract) Ultra-deep pyrosequencing of paediatric HIV-1 drug resistance and coreceptor suggests possible suitability of protease inhibitors and maraviroc at younger ages in Cameroon | J. Fokam

Presented at:

INTEREST 2016

Slidesets

Formal Debate: Resolved that 90-90-90 Cannot be Attained | Opposing the motion | Badara Samb, MD, PhD

Presented at:

INTEREST 2016

Slidesets

Formal Debate: Resolved that 90-90-90 Cannot be Attained | Affirming the motion | Isaac Tita

Presented at:

INTEREST 2016

Slidesets

(Abstract) Prevalence of non-infectious co-morbidities among HIV-positive subjects stably treated with tenofovir, lamivudine and ritonavir-boosted lopinavir in Cameroon | D. Fokom Victoire

Presented at:

INTEREST 2016

Slidesets

(Abstract) Current profile of dermatological diseases and events during HIV in Dakar | N.M.Dia

Presented at:

INTEREST 2016

Slidesets

(Abstract) Quality of life among HIV/AIDS patients on anti retro-viral therapy at Letlhakane primary hospital (Botswana): a cross sectional study | L. Kumboneki

Presented at:

INTEREST 2016

Slidesets

(Abstract) Model-based pediatric dosing of ritonavir-boosted Darunavir: an alternative to WHO guidelines | P. Mohammed

Presented at:

INTEREST 2016

Slidesets

(Abstract) Maximizing EID opportunities using the DBS Mentor Approach in Rural HIV Clinics in South-Eastern Nigeria | P. Anyanwu

Presented at:

INTEREST 2016

Slidesets

(Abstract) Getting pregnant in antiretroviral clinical trials: women choice and safety needs. Experience from the ANRS12169-2LADY and ANRS12286- MOBIDIP trials | A. Serris

Presented at:

INTEREST 2016

Slidesets

(Abstract) Retention in care among HIV-infected pregnant mothers on lifelong antiretroviral therapy (art) in Uganda | S. Muhumuza

Presented at:

INTEREST 2016

Slidesets

(Abstract) Immunologic Criteria are Poor Predictors of Virologic Outcomes: Implications for HIV Monitoring in a Large Treatment Program in Nigeria | J. Okuma

Presented at:

INTEREST 2016

Slidesets

(Abstract) Factors associated with virologic failure in HIV infected individuals in Mansa district, Zambia | G. Mutaawe

Presented at:

INTEREST 2016

Slidesets

Sustaining progress on scale-up of voluntary medical male circumcision (VMMC), including role of devices and early infant male circumcision | Zebedee Mwandi, MD

Presented at:

INTEREST 2016

Slidesets

Dolutegravir in contributing the 90:90:90 ambition | Tuna Lukiana MD, PhD

Presented at:

INTEREST 2016

Slidesets

New evidence on oral and topical PrEP for women: rings, gels, injectables | Nyaradzo Mgodi, MBChB, MMed

Presented at:

INTEREST 2016

Slidesets

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Speaker for the Opposition | François Venter, MD, FCP, PhD

Presented at:

INTEREST 2016

Slidesets

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Community Advocate | Stephen Watiti, MD

Presented at:

INTEREST 2016